Franklin Resources Inc. Raises Holdings in The Cooper Companies, Inc. $COO

Franklin Resources Inc. grew its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 108.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 4,022,033 shares of the medical device company’s stock after buying an additional 2,089,763 shares during the quarter. Franklin Resources Inc. owned 2.05% of Cooper Companies worth $329,646,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Root Financial Partners LLC lifted its stake in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the last quarter. Bell Investment Advisors Inc increased its position in shares of Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 219 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at $36,000. True Wealth Design LLC lifted its position in shares of Cooper Companies by 484.8% during the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares during the last quarter. Finally, Cromwell Holdings LLC lifted its position in shares of Cooper Companies by 128.8% during the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after purchasing an additional 273 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts recently commented on COO shares. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a report on Friday. Needham & Company LLC lowered their price objective on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday. JPMorgan Chase & Co. dropped their price objective on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a report on Friday. Rothschild & Co Redburn lowered Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price on the stock. in a research report on Wednesday, March 4th. Finally, Piper Sandler set a $86.00 price target on Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $82.64.

Cooper Companies Trading Down 0.8%

COO opened at $66.79 on Tuesday. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The business’s 50 day moving average is $64.99 and its two-hundred day moving average is $74.50. The firm has a market cap of $13.03 billion, a price-to-earnings ratio of 56.60, a price-to-earnings-growth ratio of 1.73 and a beta of 0.88.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same period in the previous year, the company posted $0.96 EPS. The company’s quarterly revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, research analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.